The integration of HR-HPV increases the expression of cyclins A and e in cytologies with and without low-grade lesions

Journal of Cytology

Volumn 30, Issue 1, 2013, Pages 1-7

  Zubillaga Guerrero, M ^a   Illades Aguiar, B ^a   Leyva Vazquez, M ^a   Flores Alfaro, E ^a   Castaneda Saucedo E ^a   Munoz Valle J ^b   Alarcon Romero L C ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Cyclin A; cyclin E; high risk human papillomavirus; in situ hybridization; low grade squamous intraepithelial lesion

Indexed keywords

EID: 84875713430     PISSN: 09709371     EISSN: 09745165     Source Type: Journal    
DOI: 10.4103/0970-9371.107504     Document Type: Article

References (29)

1. Boulet GA, Horvath CA, Berghmans S, Bogers J. Human papillomavirus in cervical cancer screening: Important role as biomarker. Cancer Epidemiol Biomarkers Prev 2008;17:810-17. (Pubitemid 351536410)
2. Carreras R, Alameda F, Mancebo G, Garcia-Moreno P, Mariñoso ML, Costa C, et al. A study of Ki-67, c-erbB2 and cyclin D1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix. Histol Histopathol 2007;22:587-92. (Pubitemid 46647271)
3. Illades-Aguiar B, Alarcón-Romero L, Antonio-Véjar V, Zamudio-López N, Sales-Linares N, Flores-Alfaro E, et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol 2010;117:291-6.
4. Tjalma WA, Van Waes TR, Van den Eeden LE, Bogers JJ. Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19:469-83. (Pubitemid 41263800)
5. Evans MF, Mount SL, Beatty BG, Cooper K. Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol 2002;15:1339-47. (Pubitemid 35463003)
6. Kalof AN, Cooper K. p16INK4a immunoexpression: Surrogate marker of high- risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol 2006;13:190-4. (Pubitemid 44341655)
7. Kulmala SM, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006;59:513-7.
8. Keating J, Cviko A, Riethdorf S, Riethdorf L, Quade B, Sun D, et al. Ki-67, cyclin E and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91. (Pubitemid 32594981)
9. Nguyen C, Münger K. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes. Virology 2008;380:21-5.
10. Erlandsson F, Martinsson-Ahlzen H, Wallin K, Hellström A, Andersson S, Zetterberg A. Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix. Br J Cancer 2006;94:1045-50.
11. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System. JAMA 2002;287:2114-9.
12. Leonard D, Michael K, James B. Basic methods in molecular biology. 2st ed. Connecticut: Appleton and Lange; 1994.
13. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
14. Muñoz N, Bosch X, Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
15. Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. In vivo ciclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11:1238-46. (Pubitemid 29009335)
16. Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR. Comparison of ProExC with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: A pilot study. Cancer 2008;114:474-80.
17. Saqi A, Pasha TL, McGrath CM, Yu GH, Zhang P, Gupta P. Overexpression of p16INK4a in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002;27:365-70. (Pubitemid 35424172)
18. Sahebali S, Depuydt CE, Boulet GA, Arbyn M, Moeneclaey LM, Vereecken AJ, et al. Immunocytochemistry in liquid-based cervical cytology: Analysis of clinical use following a cross-sectional study. Int J Cancer 2006;118:1254-60. (Pubitemid 43185614)
19. Peitsaro P, Johansson B, Syrjänen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91. (Pubitemid 34208640)
20. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004;64:3878-84. (Pubitemid 38697299)
21. Gallo G, Bibbo M, Bagella L, Zamparelli A, Sanseverino F, Giovagnoli MR, et al. Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol 2003;56:532-6. (Pubitemid 36819426)
22. Li Y, Xiang Y, Zhang R, Cai YP, Yang Y, Cheng XM, et al. Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions. Zhonghua Yi Xue Za Zhi 2011;91:906-10.
23. Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, et al. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 2008;46:3678-85.
24. Coutlée F, Trottier H, Gagnon S, Koushik A, Richardson H, Roger M, et al. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. J Clin Virol 2009;45:96-9.
25. Doorbar J. Thepapillomaviruslife cycle. J Clin Virol2005;32 Suppl 1:S7-15.
26. Kitkumthorn N, Yanatatsanajit P, Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P, et al. Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer. BMC Cancer 2006;6:1-9.
27. Skomedal H, Kristensen G, Lie A, Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 1999;73:223-8. (Pubitemid 29215735)
28. Shiohara S, Shiozawa T, Miyamoto T, Feng YZ, Kashima H, Kurai M, et al. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: Overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease. Virchows Arch 2005;44:626-33. (Pubitemid 40922268)
29. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 1998;82:1709-19. (Pubitemid 28208922)